We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > AndroGel

News List

Aleor Dermaceuticals gets USFDA Final nod for Testosterone Gel expresspharma
March 04, 2021
Testosterone Gel is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.
Teva launches generic AndroGel biospectrumasia
April 22, 2019
Testosterone Gel 1.62% CIII is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone
AbbVie strikes tentative deal to settle 4,000-plus AndroGel lawsuits fiercepharma
September 12, 2018
Lawyers for AbbVie and AndroGel plaintiffs have reached a potential settlement, Judge Matthew Kennelly wrote in a Monday court filing.
Judge strikes $140M AndroGel verdict after AbbVie appeal fiercepharma
July 09, 2018
Right on the heels of a legal setback relating to AndroGel antitrust claims, AbbVie has scored a reversal of a $140 million verdict in the case of a plaintiff who argued the company's testosterone drug caused his heart attack.